Medical professionals are often unprepared for conversations with their patients regarding cannabis. Unfortunately, many patients are turning to retail sellers for answers. Evidence-based certified CE courses on the subject have been difficult to find until now. Introducing the medical cannabis CE course written by Dr. Kevin F. Smith.
Dr. Kevin Smith, MD, MPH- 30+ years in clinical practice
- Seven years involved with alternative therapies in response to the opioid crisis
- Board certified in Preventive Medicine
- Masters of Public Health from Yale University
The course is fully certified offering 3.25 ACPE credits. The video-based modules feature current science and practical guidelines, as well as medical references throughout, with adaptive self-assessment and guided remediation. This course provides the clinical knowledge that medical professionals need to engage in informed discussion with their patients.
This cannabis CE course contains four separate learning modules. Each module is in a video format with post-viewing self-assessment questions and answers. Designed to demystify a controversial subject with scientifically backed answers, this course will give you the information you need to answer your patients’ questions about Medical Cannabis.
- Module 01 - The Endocannabinoid System
- Module 02 - FDA Approved Cannabinoid Medications
- Module 03 - Managing Chronic Pain and Decreasing Opioid Use with Medical Cannabis
- Module 04 - Pharmacogenetics and Cannabinoid Medications
Educational Objectives:
After completing this knowledge-based activity, the participant should be better able to:
The Endocannabinoid System
- Explain the importance of the ECS for maintaining multiple centers in the brain and the organ systems in the body in homeostasis in response to oxidative stressors.
- List the components and functions of the ECS
- Articulate various therapeutic approaches that utilize the ECS
FDA-Approved Cannabinoid Medications
- Discuss emerging therapeutic agents involving new combinations of CBD and THC
- Identify the ingredients of plant extract cannabinoid medications.
- Compare and contrast the various compounding differences of cannabinoid medications
- Describe receptor activity differences of synthetic versus naturally occurring cannabinoids
Managing Chronic Pain and Decreasing Opioid Use
- Discuss how the innate opioid and cannabinoid systems interact to impact nociception
- Distinguish between CB1 and CB2 components of the ECS on pain
- Describe dosing strategies with cannabinoids to address opioid sparing early in pain management
- Identify dosing strategies with cannabinoids when tapering opioids in patients with chronic or opioid histories
Pharmacogenetics and Cannabinoid Medications
- Identify Pharmacogenetics and Cannabinoid Medications
- List enzymes within the p450 system with known variants
Highlights
- 45 questions for review and retention
- Adaptive self-assessment with guided remediation
- Earn up to 3.25 ACPE credits
Faculty
Author:
Kevin Smith, MD, MPH
Medical Director
Health Management Solutions
Presenter:
Lisa Drost, ND, LDN, CNS
Naturopathic Doctor
Oaktree Wellness Center
Provider Statement
 |
The University of Maryland School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is jointly provided by the University of Maryland School of Pharmacy and Challenger Corporation. |
Disclosure of Conflicts of Interest
Drs. Kevin Smith and Lisa Drost have no financial relationships to disclose. None of the planners for this activity have any financial relationships to disclose.
Cannabis Medical Education CE
